Health Condition 1: N979- Female infertility, unspecified
Conditions
Interventions
Intervention1: Probiotic drug containing lactobacillus crispatus: For 3 months
Intervention2: Probiotic containing lactobacillus crispatus: For 3 months
Control Intervention1: Placebo: For 3 months
Sponsors
Aashima Atrey
Eligibility
Inclusion criteria
Inclusion criteria: Women with normal ovulating cycles, normal uterine cavity, and at least unilateral patent tube Men with normal HSA
Exclusion criteria
Exclusion criteria: Couples with HIV hepatitis B, hepatitis and hepatitis C Woman with PID Couples with systemic disease like diabetes, hypertension and tuberculosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of woman with lactobacillus crispatus dominant endometrium versus non-dominant endometrium before and after 3 months of probiotic/placebo supplementationTimepoint: The proportion of woman with lactobacillus crispatus dominant endometrium versus non-dominant endometrium before and after 3 months of probiotic/placebo supplementation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The number of women with positive UPT after a missed period in each group 2. Number of women with confirmed card activity 6 to 7 weeks of gestation in each group.Timepoint: | — |
Countries
India
Contacts
Public ContactDR BHANUPRIYA
Guru teg Bahadur hospital Dilshad garden, shahdara Delhi
Outcome results
None listed